We investigate general HIV infection models with three types of infected cells: latently infected cells, long-lived productively infected cells, and short-lived productively infected cells. We incorporate three discrete or distributed time delays into the models. Moreover, we consider the effect of humoral immunity on the dynamical behavior of the HIV. The HIV-target incidence rate, production/proliferation, and removal rates of the cells and HIV are represented by general nonlinear functions. We show that the solutions of the proposed model are nonnegative and ultimately bounded. We derive two threshold parameters which fully determine the existence and stability of the three steady states of the model. Using Lyapunov functionals, we establish the global stability of the steady states of the model. The theoretical results are confirmed by numerical simulations.
Introduction
Mathematical modeling and analysis of within-host human immunodeficiency virus (HIV) dynamics have become one of the hot topics during the last decades . These works can help researchers better understand the HIV dynamical behavior and provide new suggestions for clinical treatment. Most of the mathematical models presented in the literature have focused on modeling the interaction between three main compartments: uninfected CD4 + T cells (s), infected cells (y), and free HIV particles (p). Other models have differentiated between latent and active infected cells by introducing a new variable (w) for the latently infected cells [32] [33] [34] [35] [36] [37] . In [38] , an HIV mathematical model has been presented by considering three types of infected cells: latently infected cells (w), short-lived productively infected cells (y), and long-lived productively infected cells (u) as follows:
s(t) = ρ -β 1 s(t) + ωs(t) 1 -s(t) s max
-(1 -ε 1 )(λ 1 + λ 2 + λ 3 )s(t)p(t),
w(t) = (1 -ε 1 )λ 1 s(t)p(t) -(a 1 + β 2 )w(t),
y(t) = (1 -ε 1 )λ 2 s(t)p(t) + a 1 w(t) -β 3 y(t),

u(t) = (1 -ε 1 )λ 3 s(t)p(t) -β 4 u(t),
p(t) = (1 -ε 2 )Nβ 3 y(t) + (1 -ε 2 )Mβ 4 u(t) -β 5 p(t),
where ρ is the creation rate of the uninfected CD4 + T cells, β i , i = 1, . . . , 5, are the death rate constants of the five compartments s, w, y, u, and p, respectively. The model incorporates reverse transcriptase inhibitor (RTI) with efficacy ε 1 and protease inhibitor (PI) with efficacy ε 2 , where ε 1 , ε 2 ∈ [0, 1]. The parameters ω and s max are the maximum proliferation rate and the maximum level of concentration of the uninfected CD4 + T cells, respectively.
The latently infected cells are activated at rate a 1 w. The parameters N and M are the average numbers of HIV particles generated in the lifetime of the short-lived and long-lived infected cells, respectively. The uninfected CD4 + T cells become infected with infectivity λ 1 + λ 2 + λ 3 . Elaiw et al. [27] have generalized the above model by incorporating the humoral immune response and considering general nonlinear functions for the generation and removal rates of all compartments:
w(t) = (1 -ε 1 )λ 1 χ s(t), p(t) -(a 1 + β 2 )g 1 w(t) ,
y(t) = (1 -ε 1 )λ 2 χ s(t), p(t) + a 1 g 1 w(t) -β 3 g 2 y(t) ,
u(t) = (1 -ε 1 )λ 3 χ s(t), p(t) -β 4 g 3 u(t) ,
p(t) = (1 -ε 2 )Nβ 3 g 2 y(t) + (1 -ε 2 )Mβ 4 g 3 u(t)
x(t) = rg 4 p(t) g 5 x(t) -β 6 g 5 x(t) ,
where x represents the concentration of the B cells. π , χ , g i , i = 1, . . . , 5, are general nonlinear functions. Model (6)- (11) assumes that, once the HIV contacts a CD4 + T cell, it becomes infected in the same time. Neglecting the time delays is an unrealistic assumption (see, e.g., [29, 30] ). The aim of this paper is to propose HIV infection models which improve model (6)-(11) by taking into account three time delays, discrete or distributed. We derive two threshold parameters and present some mild sufficient conditions for the existence and global stability of the steady states of the models.
HIV dynamics model with discrete delays
We formulate a nonlinear HIV dynamics model with latent reservoirs, humoral immunity, and discrete time delays: s = π s(t) -(1 -ε 1 )(λ 1 + λ 2 + λ 3 )χ s(t), p(t) , (12) w = (1 -ε 1 )λ 1 e -μ 1 τ 1 χ s(t -τ 1 ), p(t -τ 1 ) -(a 1 + β 2 )g 1 w(t) ,
y = (1 -ε 1 )λ 2 e -μ 2 τ 2 χ s(t -τ 2 ), p(t -τ 2 ) + a 1 g 1 w(t) -β 3 g 2 y(t) ,
u = (1 -ε 1 )λ 3 e -μ 3 τ 3 χ s(t -τ 3 ), p(t -τ 3 ) -β 4 g 3 u(t) , 
All the parameters are positive. Here, τ 1 is the time between viral entry and latent infection (i.e., the integration of viral DNA into cell's DNA has finished), while τ 2 and τ 3 are the times between viral entry and viral production form short-lived productively infected and long-lived productively infected cells, respectively. The factor e -μ i τ i accounts for the loss of target cells during the delay period of length τ i , where μ i is a constant. Let us define λ i = (1 -ε 1 )λ i , i = 1, 2, 3, N = (1 -ε 2 )N, M = (1 -ε 2 )M, and λ = λ 1 + λ 2 + λ 3 . Functions χ , π , g i , i = 1, . . . , 5, are continuously differentiable and satisfy the following hypotheses: 
) ≤ 0 for p ∈ (0, ∞). We consider system (12)-(17) with the initial conditions:
where ς = max{τ 1 , τ 2 , τ 3 } and C is the Banach space of continuous functions mapping the interval [-ς, 0] into R 6 ≥0 . Then the uniqueness of the solution for t > 0 is guaranteed [39] . 
Preliminaries
T , and
We have
Using Lemma 2 in [40] , the solutions of system (12)- (17) with the initial states (18) satisfy X(t) ∈ R . Let
where σ = min{b, β 2 α 1 ,
. The nonnegativity of the system's variables implies that
Therefore, s(t), w(t), y(t), u(t), p(t)
, and x(t) are ultimately bounded.
According to Lemma 1, we can show that the region
is positively invariant with respect to system (12)- (17), where φ = sup t→∞ φ(t). 
Lemma 2 Suppose that hypotheses
From Eq. 
where
It follows from Eqs. (20)- (24) that
Obviously, ψ i (s) > 0 for s ∈ [0, s 0 ) and ψ i (s 0 ) = 0, i = 1, . . . , 4. From Eqs. (20), (26) , and (27) we obtain
Equation (28) admits a solution s = s 0 which gives the infection-free steady state 0 (s 0 , 0, 0, 0, 0, 0). Let
It is clear from hypotheses (H1) and (H2) that 1 (0) = -g 4 (ψ 4 (0)) < 0 and 1 (s 0 ) = 0. Moreover,
We note from hypothesis (H2) that
From Eq. (26), we get
Hence, from hypothesis (H1), we have π (s 0 ) < 0. Therefore, if 
It means that a humoral-inactivated infection steady state 1 (s 1 , w 1 , y 1 , u 1 , p 1 , 0) exists when (24) and (27) that
β 6 r > 0,
Thus,
> 1. Now we define the humoral immune response activation number as follows:
(
(R 1 -1)) > 0, and there exists a humoral-activated infection steady state 2 (s 2 , w 2 , y 2 , u 2 , p 2 , x 2 ).
Clearly, from hypotheses (H2) and (H4), we have
We will use the following equalities throughout the paper:
Global properties
The following theorems investigate the global stability of the steady states of system (12)- (17) . Let us define the function
), w(t), y(t), u(t), p(t), x(t)).
Theorem 1 If R 0 ≤ 1 and hypotheses (H1)-(H4) are valid, then 0 is globally asymptotically stable (GAS).
Proof Define a Lyapunov functional V 0 as follows:
The solution of Eqs. (31) is given by
We calculate dV 0 dt along the trajectories of (12)- (17) as follows:
Collecting terms of Eq. (33) and using π(s 0 ) = 0, we obtain
By hypotheses (H1) and (H2), we obtain
= 0 at 0 . Applying LaSalle's invariance principle (LIP), we get that 0 is GAS.
Lemma 3 If R 0 > 1 and hypotheses (H1)-(H4) are valid, then
Proof Using hypotheses (H1) and (H2), for
and from hypothesis (H4), we obtain
First, we show that sgn(
. Using the steady state conditions of 1 and 2 , we obtain
Therefore, from inequalities (34)- (36) we obtain sgn(s 2 -s 1 ) = sgn(s 1 -s 2 ), which is a contradiction; hence, sgn(p 1 -p 2 ) = sgn(s 2 -s 1 ). Using Eq. (29) and the definition of R 1 , we get
Thus, from Eqs. (35) and (37) we obtain sgn(R 1 -1) = sgn(p 1 -p 2 ).
Theorem 2
If R 1 ≤ 1 < R 0 and hypotheses (H1)-(H4) are valid, then 1 is GAS.
Proof Let
Calculating dV 1 dt along the solutions of (12)- (17), we obtain
Collecting terms of Eq. (38) and applying the conditions of the steady state 1
we get
Using inequalities (30) withŝ = s 1 ,ŵ = w 1 ,ŷ = y 1 , andp = p 1 , we can obtain
Hypotheses (H1), (H2), (H4), Lemma 3, and the condition R 1 ≤ 1 imply that Proof Define
along the solutions of model (12)- (17), we get
Collecting terms of Eq. (40) and using the steady state conditions for 2 :
we obtain
By inequalities (30) withŝ = s 2 ,ŵ = w 2 ,ŷ = y 2 , andp = p 2 , we can get
According to hypotheses (H1), (H2), and (H4), we get dV 2 dt ≤ 0 and
= 0 at 2 . LIP implies that 2 is GAS.
Model with delay-distributed
In the next model, we consider a general delay-distributed HIV infection model with humoral immunity as follows:
where f i (τ )e -μ i τ over the time interval [0, h i ], i = 1, 2, 3, represent the probabilities that uninfected cells contacted by HIV at time t -τ survived τ time units and became infected at time t. The probability distribution function f i (τ ) is assumed to satisfy f i (τ ) > 0 and
where υ is a positive constant. Let us denote i (τ ) = f i (τ )e -μ i τ and 
Hence, lim sup t→∞ G(t) ≤
(t), w(t), y(t), u(t), p(t)
, and x(t) are ultimately bounded. Moreover, the set defined by (19) is also positively invariant with respect to system (42)-(47). 
Steady states
From Eqs. (48)- (53) we can get From Eq. (54), we get
Therefore, using hypothesis (H1), we get π (s 0 ) < 0. So that, if 
Thus, x 2 > 0 when ζ χ(s 2 ,p 2 ) g 4 (p 2 ) > 1. Let us define the parameter R 1 as follows:
Global properties
Theorem 4 If R 0 ≤ 1 and hypotheses (H1)-(H4) hold true for system (42)-(47), then 0 is GAS.
Proof Define
The solution of Eqs. (59) is given by
We evaluate dW 0 dt along the solutions of (42)- (47) as follows:
Collecting terms of Eq. (61) and using π(s 0 ) = 0, we obtain
From hypotheses (H1) and (H2), we have
≤ 0. Thus, 0 is GAS.
Theorem 5
If R 1 ≤ 1 < R 0 and hypotheses (H1)-(H4) are valid for (42)-(47), then 1 is GAS.
Proof We introduce
along the trajectories of (42)- (47), we have
Collecting terms of Eq. (63) and applying the conditions of the steady state 1 :
Using inequalities (30) withŝ = s 1 ,ŵ = w 1 ,ŷ = y 1 ,p = p 1 , and τ 1 = τ 2 = τ 3 = τ , we can obtain
Using hypotheses (H1), (H2), (H4), and Lemma 3, we get Proof Define
along the solutions of model (42)- (47), we get
Collecting terms of Eq. (64) and applying the steady state conditions for 2 :
Using inequalities (30) withŝ = s 2 ,ŵ = w 2 ,ŷ = y 2 ,p = p 2 , and τ 1 = τ 2 = τ 3 = τ , we can obtain
According to hypotheses (H1), (H2), and (H4), we get dW 2 dt ≤ 0. Applying LIP, one can show that 2 is GAS.
Numerical simulations
We now perform some computer simulations on the following application:
We assume that ω < β 1 . In this application, we consider the following specific forms of the general functions:
First we verify hypotheses (H1)-(H4) for the chosen forms, then we solve the system using MATLAB. Clearly, π(0) = ρ > 0 and π(s 0 ) = 0, where
Clearly, π(s) > 0 for s ∈ [0, s 0 ) and 
It follows that (H2) is satisfied. Clearly, hypothesis (H3) holds true. Moreover,
Therefore, hypothesis (H4) holds true and Theorems 1-3 are applicable. The parameters R 0 and R 1 for this application are given by
Remark There are several forms of the general function χ(s, p) where (H1)-(H4) can be satisfied such as:
Now we are ready to perform some numerical simulations for system (66)-(71). The data of system (66)-(71) are provided in Table 1 . We let τ 1 = τ 2 = τ 3 = τ .
•Effect of the parameters λ i and r on the stability of the steady states Let us address three cases for the parameters λ i , i = 1, 2, 3, and r. We assume that ε 1 = ε 2 = 0 (there is no treatment) and τ i = 0 (there is no time delay).
Case (I): Choose λ i = 0.0000625 and r = 0.005, which gives R 0 = 0.3016 < 1 and R 1 = 0.1917 < 1. Therefore, based on Lemma 2 and Theorem 1, the system has unique steady state, that is, 0 , and it is GAS. As we can see from Figs. 1-6, the concentration of the uninfected CD4 + T cells is increased and approaches its normal value before infection, Figure 3 The concentration of short-lived productively infected cells for system (66)-(71) Figure 4 The concentration of long-lived productively infected cells for system (66)- (71) that is, s 0 = 1001.98; while concentrations of the other compartments converge to zero for all the three initial conditions. As a result, the HIV-1 is removed from the plasma. conditions. In this case the humoral immune response is activated and can control the disease.
Case (II):
•
Effect of the HAART on the HIV dynamics
We take τ i = 0, λ i = 0.000625, and r = 0.05. We choose the initial conditions (s(0), w(0), y(0), u(0), p(0), x(0)) = (850, 5, 6, 17, 1.5, 5). In Figs. 7-12 we show the effect of the drug efficacy parameters ε 1 and ε 2 on the HIV dynamics. Also, we can observe that, as the drug efficacy parameters ε 1 and ε 2 are increased, the concentration of uninfected cells is increased, while the concentrations of free virus particles and the three types of infected cells are decreased. Table 2 shows that the values of R 0 and R 1 are decreased as ε 1 and ε 2 are increased.
Let us define the overall HAART effect as ε e = ε 1 + ε 2 -ε 1 ε 2 [13] . If ε e = 0, then the HAART has no effect, if ε e = 1, the HIV growth is completely halted. Consequently, the Since the goal is to clear the viruses from the body, we have to determine the drug efficacy that makes R 0 (ε e ) ≤ 1 for system (66)-(71). In this case, we get the critical drug efficacy (i.e., the efficacy needed in order to stabilize the system around the uninfected steady state). For the model (66)-(71), 0 is GAS when R 0 (ε e ) ≤ 1, i.e., Using the data in Table 1 , we have ε Table 3 show Figure 13 The concentration of uninfected CD4 + T cells for system (66)-(71) Figure 14 The concentration of latently infected cells for system (66)- (71) the effect of the time delay parameter τ on the stability of 0 , 1 , and 2 . Clearly, the parameter τ has similar effect as the drug efficacy parameters ε 1 and ε 2 .
Conclusion
In this paper, we have proposed and analyzed two general nonlinear HIV infection models with humoral immune response. We have considered three types of infected cells: latently infected cells, long-lived productively infected cells, and short-lived productively infected cells. We have incorporated three discrete or distributed time delays into the models. We have considered more general nonlinear functions for the HIV-target incidence rate, pro- Figure 15 The concentration of short-lived productively infected cells for system (66)-(71) Figure 16 The concentration of long-lived productively infected cells for system (66)- (71) duction/proliferation, and removal rates of the cells and HIV. We have derived a set of conditions on these general functions and have determined two threshold parameters: the basic reproduction number R 0 and the humoral immune response activation number R 1 . We have proved the nonnegativity and ultimate boundedness of the model's solutions and the existence and stability of the model's steady states. Using Lyapunov functionals, we have established the global stability of the three steady states of the models. We have presented an example and performed some numerical simulations to support our theoretical results. 
